“Deucravacitinib in Moderate to Severe Plaque Psoriasis: Comorbidities and Use of Prior and Concomitant Medication in Patients Enrolled in the Phase 3 POETYK PSO-1 and PSO-2 Trials”, J of Skin, vol. 8, no. 6, p. s428, Nov. 2024, doi: 10.25251/skin.8.supp.428.